Evidence map›Paper›PMID 25633778›Full record

ArticleInternational journal of hematology2015

PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).

Kazuyuki Sato, Hirotaka Sakai, Masayuki Kato, Yuji Nishio, Yuka Tsuruoka, Yu Uemura, Satoshi Yokoi, Tasuku Saito, Manabu Matsunawa, Yoshinori Suzuki and 4 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Kazuyuki SatoDivision of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Hirotaka Sakai
Masayuki Kato
Yuji Nishio
Yuka Tsuruoka
Yu Uemura
Satoshi Yokoi
Tasuku Saito
Manabu Matsunawa
Yoshinori Suzuki
Yasushi Isobe
Yasuyuki Inoue
Masatomo Takahashi
Ikuo Miura
St. Marianna University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe herein the case of a 64-year-old man with a diagnosis of plasma cell myeloma (PCM). A chromosome analysis based on G-banding and spectral karyotyping revealed the following complex karyotype: 46,XY,del(3)(p?), t(4;15)(q31;q24),t(9;14;11)(p13;q32;q13),add(15)(q24),add(18)(q21). Fluorescence in situ hybridization (FISH) detected one signal each for the immunoglobulin heavy chain (IGH) and cyclin D1 (CCND1) genes, and three fusion signals of IGH and CCND1. FISH analysis of metaphase spreads revealed fusion signals on the derivative chromosomes 9, 11, and 14. Immunohistochemical analysis identified abnormal expression of CCND1 and PAX5. PAX5-positive PCM is rare because the down-regulation of PAX5 is essential for the terminal differentiation of B cells into plasma cells. To the best of our knowledge, this is the first reported case of a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).

Indexed as

Translocation, GeneticChromosome BandingChromosomes, Human, Pair 11Chromosomes, Human, Pair 14Chromosomes, Human, Pair 9Cyclin D1Gene Expression Regulation, NeoplasticHumansImmunoglobulin Heavy ChainsIn Situ Hybridization, FluorescenceKaryotypingMaleMiddle AgedMultiple MyelomaPAX5 Transcription FactorPlasma CellsCCND1 protein, humanCyclin D1Immunoglobulin Heavy ChainsPAX5 protein, humanPAX5 Transcription Factor

Identifiers

PMID25633778
OpenAlexW2069767497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.